Viridian Therapeutics, Inc. 0K1R.L
0K1R.L
Viridian Therapeutics, Inc. 0A8E.L
Xeris Biopharma Holdings, Inc. 0LDR.L
Teladoc Health, Inc. 0L35.L
Sarepta Therapeutics, Inc. 0HQ1.L
Azenta, Inc. 0KCS.L
OPKO Health, Inc. 0HB0.L
Agios Pharmaceuticals, Inc. 0JBU.L
Intellia Therapeutics, Inc. 0HF9.L
Amicus Therapeutics, Inc. 0IV3.L
Geron Corporation
Viridian Therapeutics, Inc. 0A8E.L
Xeris Biopharma Holdings, Inc. 0LDR.L
Teladoc Health, Inc. 0L35.L
Sarepta Therapeutics, Inc. 0HQ1.L
Azenta, Inc. 0KCS.L
OPKO Health, Inc. 0HB0.L
Agios Pharmaceuticals, Inc. 0JBU.L
Intellia Therapeutics, Inc. 0HF9.L
Amicus Therapeutics, Inc. 0IV3.L
Geron Corporation
Performance
| Periode | 0K1R.L | 0A8E.L | 0LDR.L | 0L35.L | 0HQ1.L | 0KCS.L | 0HB0.L | 0JBU.L | 0HF9.L | 0IV3.L |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 67.50 % | 115.63 % | 27.86 % | -61.24 % | 16.41 % | 3.61 % | 47.07 % | 69.44 % | 20.71 % | -8.60 % |
| YTD | 15.79 % | 165.72 % | -6.26 % | -81.45 % | -35.83 % | -2.65 % | 30.59 % | 20.29 % | -5.84 % | -65.00 % |
| 1Y | -4.38 % | 187.73 % | -1.68 % | -82.05 % | -23.46 % | -1.99 % | -5.51 % | -10.98 % | -23.55 % | -69.61 % |
| 3Y | 13.08 % | 730.09 % | -68.72 % | -79.46 % | -28.32 % | -22.85 % | 55.39 % | -72.13 % | -14.56 % | -46.62 % |
| 5Y | -18.00 % | 730.09 % | -88.41 % | -69.79 % | -55.85 % | -52.29 % | 27.96 % | -84.87 % | -7.13 % | -26.56 % |
| 10Y | -82.34 % | 730.09 % | -88.41 % | -69.79 % | 9.33 % | -52.29 % | -45.85 % | -84.87 % | -7.13 % | -37.10 % |
| Depuis le début | -82.34 % | 730.09 % | -88.41 % | -69.79 % | 9.33 % | -52.29 % | -45.85 % | -84.87 % | -7.13 % | -37.10 % |